Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 7160 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 10185 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 10980 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 11624 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 12566 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 15343 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 15891 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 16768 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 18073 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 20064 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 24424 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 27036 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | 35050 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | CORTISONE (M+CL)- | Peak area normalized | female | diabetic | no neuropathy |